Zolpidem tartrate and Haemangioma of skin - a phase IV clinical study of FDA data

Summary:

Haemangioma of skin is found among people who take Zolpidem tartrate, especially for people who are female, 30-39 old.

The phase IV clinical study analyzes which people take Zolpidem tartrate and have Haemangioma of skin. It is created by eHealthMe based on reports of 27,192 people who have side effects when taking Zolpidem tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

27,192 people reported to have side effects when taking Zolpidem tartrate.
Among them, 6 people (0.02%) have Haemangioma of skin.

What is Zolpidem tartrate?

Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 28,222 Zolpidem tartrate users for its effectiveness, alternative drugs and more.

What is Haemangioma of skin?

Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 536 drugs and 280 conditions by eHealthMe.

Number of Zolpidem tartrate and Haemangioma of skin reports submitted per year:

Could Zolpidem tartrate cause Haemangioma of skin?

Gender of people who have Haemangioma of skin when taking Zolpidem tartrate *:

female: 83.33 %
male: 16.67 %

Age of people who have Haemangioma of skin when taking Zolpidem tartrate *:

Common drugs people take besides Zolpidem tartrate *:

Ambien: 5 people, 83.33%
Lorazepam: 5 people, 83.33%
Ativan: 5 people, 83.33%
Lansoprazole: 5 people, 83.33%
Lortab: 4 people, 66.67%
Fenofibrate: 4 people, 66.67%
Naloxone: 4 people, 66.67%
Morphine: 4 people, 66.67%
Liothyronine Sodium: 4 people, 66.67%
Ketorolac Tromethamine: 4 people, 66.67%

Common side effects people have besides Haemangioma of skin *:

Abdominal Pain: 5 people, 83.33%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 5 people, 83.33%
High Blood Pressure: 5 people, 83.33%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 83.33%
Dizziness: 5 people, 83.33%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 83.33%
Bone Pain: 5 people, 83.33%
Neuropathy Peripheral (surface nerve damage): 5 people, 83.33%
Sinusitis (inflammation of sinus): 5 people, 83.33%
Memory Loss: 4 people, 66.67%

Common conditions people have *:

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 66.67%
Upper Respiratory Tract Infection: 1 person, 16.67%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 16.67%
Pain: 1 person, 16.67%
Muscle Spasms (muscle contraction): 1 person, 16.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 16.67%
Ill-Defined Disorder: 1 person, 16.67%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem tartrate and have Haemangioma of skin?

Check whether Haemangioma of skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .

Related studies

Browse all side effects of Zolpidem tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Haemangioma of skin treatments and more:

Haemangioma of skin (542 reports)

COVID vaccines that are related to Haemangioma of skin:

Common drugs associated with Haemangioma of skin:

Gilenya: 174 reports

All the drugs that are associated with Haemangioma of skin:

Haemangioma of skin (536 drugs)

Common conditions associated with Haemangioma of skin:

Multiple sclerosis: 177 reports

All the conditions that are associated with Haemangioma of skin:

Haemangioma of skin (280 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem tartrate) and Zolpidem tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.